115 related articles for article (PubMed ID: 12722679)
1. [Clinical study of TS-1 therapy for inoperable and recurrent gastric cancer].
Moriwaki T; Hyodo I; Nishina T; Kajiwara T; Tsuzuki T; Hirao K; Nakauchi M; Nasu J; Hirasaki S; Endo H; Masumoto T; Tanimizu M; Kubo Y; Kurita A
Gan To Kagaku Ryoho; 2003 Apr; 30(4):489-94. PubMed ID: 12722679
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of individual TS-1 therapy for inoperable gastric cancer].
Kubo S; Misawa T; Yoshida K; Nasu T; Ihara Y; Chinen T; Harada N; Nawada H
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1161-5. PubMed ID: 12145996
[TBL] [Abstract][Full Text] [Related]
4. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
[TBL] [Abstract][Full Text] [Related]
5. [Results of treatment of far advanced and recurrent stomach cancer with TS-1].
Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632
[TBL] [Abstract][Full Text] [Related]
6. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
7. [The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination].
Inaba Y; Watabe S; Ohe S; Kamio Y; Koyama M; Hayashi K; Chiba M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):239-44. PubMed ID: 11865630
[TBL] [Abstract][Full Text] [Related]
8. Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.
Osugi H; Takada N; Takemura M; Kaseno S; Lee S; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
Oncol Rep; 2002; 9(4):811-5. PubMed ID: 12066214
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1297-301. PubMed ID: 14518409
[TBL] [Abstract][Full Text] [Related]
11. [A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session].
Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1403-9. PubMed ID: 12214468
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of S-1 for advanced gastric cancer after reduction surgery].
Inaba Y; Hayashi K; Miura T; Moriya T; Takiguchi M; Isobe H; Watabe S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1053-7. PubMed ID: 17637541
[TBL] [Abstract][Full Text] [Related]
13. [Complete response in a case of recurrent gastric cancer treated with TS-1].
Yano T; Ono H; Watanabe Y; Sato M
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1461-4. PubMed ID: 12214478
[TBL] [Abstract][Full Text] [Related]
14. [Complete response in an elderly patient with advanced gastric cancer treated with TS-1].
Ijuin H; Tokitou D; Adachi E; Imamura K; Imamura S; Arima T; Atsuchi Y; Nakano K; Kotobuki S
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2165-8. PubMed ID: 15628764
[TBL] [Abstract][Full Text] [Related]
15. [A case of effective response to TS-1 of inoperable gastric cancer, in the course of chemotherapy for malignant lymphoma].
Fujita T; Fukuda K; Nishi H; Takao T; Ohmura Y; Mano M; Komatsubara S; Yano T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1977-81. PubMed ID: 14650971
[TBL] [Abstract][Full Text] [Related]
16. [A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
Hatanaka F; Matsuo S; Aratake Y; Uchimura K; Yokota M; Sumii T; Iguchi H; Funakoshi A
Gan To Kagaku Ryoho; 2003 May; 30(5):703-6. PubMed ID: 12795106
[TBL] [Abstract][Full Text] [Related]
17. [Case reports of use of TS-1 for second/third-line chemotherapy for advanced colorectal carcinoma].
Kabeshima Y; Takahashi Y; Kameyama N; Toizumi A; Tamura Y; Kageyama T
Gan To Kagaku Ryoho; 2005 Jun; 32(6):873-5. PubMed ID: 15984535
[TBL] [Abstract][Full Text] [Related]
18. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
[TBL] [Abstract][Full Text] [Related]
19. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
20. [A case report of advanced cardiac cancer showing a complete response to TS-1 as neoadjuvant chemotherapy].
Yamamoto Y; Kino Y; Ohara K; Onuma S; Asai K; Kobayashi T; Kono T; Kasai S
Gan To Kagaku Ryoho; 2004 Apr; 31(4):579-83. PubMed ID: 15114703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]